(PharmaNewsWire.Com, May 03, 2017 ) Browse 197 market data tables and 53 figures spread through 200 pages and in-depth TOC on “Behavioral/Mental Health Software Market”
Early buyers will receive 10% customization on this report.
Market Dynamics:
The global behavioral health software market involves functionalities that help the behavioral health end users to increase their efficiency and reduce healthcare cost. This market is driven by several factors which include behavioral health reforms, government initiatives for improving behavioral healthcare services across the globe, and the rising number of people seeking behavioral health support.
The relatively untapped Asian market and increasing adoption rate of subscription model have opened an array of opportunities for growth of the market. However, lower adoption rate of behavioral health EHRs, data privacy concerns, and dearth of psychiatrists and healthcare IT professionals are expected to restrain the growth of this market.
Based on geography, the global behavioral health software market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW).
North America is expected to account for the largest share of the market by the end of 2014. The growth of this market is driven by factors such as increasing government support for expanding behavioral health services, behavioral health reforms, and rising patient base seeking behavioral health services.
Key players in the behavioral health software market include Netsmart Technologies (U.S.), Qualifacts (U.S.), Cerner Corporation (U.S.), Epic Systems Corporation (U.S.), MindLinc (U.S.), Credible Behavioral Health Software (U.S.), Accumedic (U.S.), Askesis Development Group, Inc. (U.S.), BestNotes (U.S.), Valant Medical Solutions, Inc. (U.S.), Welligent, Inc. (U.S.), and NextGen Healthcare (U.S.), amongst others.
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: